Mosaic ImmunoEngineering (CPMV) Current Deferred Revenue (2011)
Mosaic ImmunoEngineering (CPMV) reported Current Deferred Revenue of $13,412 for Q2 2012, down 57.7% from the prior quarter.
Powered by 
Analysis
Mosaic ImmunoEngineering (CPMV) Current Deferred Revenue (2011) Analysis & Trends
At the end of FY2011, Mosaic ImmunoEngineering posted Current Deferred Revenue of $50,502.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Mosaic ImmunoEngineering | 434,528.21 | 434,528.21 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2011 | 13,412.00 |
| Aug 31, 2011 | 31,674.00 |
| May 31, 2011 | 50,502.00 |
API Access
Mosaic ImmunoEngineering Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CPMV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CPMV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CPMV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();